Ashwin Pinto

Honorary Senior Lecturer

University of Southampton

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Ashwin Pinto is an Honorary Senior Lecturer at the University of Southampton, United Kingdom. His research focuses on neurological disorders, evidenced by his recent publications on autoimmune myasthenia gravis management, personal health records for neurologists, and COVID-19-related studies. Dr. Pinto is also involved in clinical trials and systematic reviews, particularly concerning amyotrophic lateral sclerosis and various epilepsy treatments.

Articles (13)

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (10)

Catrin Plumpton

Bangor University

UNITED KINGDOM

View details

Rhys Roberts

University of Cambridge

UNITED KINGDOM

View details

Luke Slater

University of Birmingham

UNITED KINGDOM

View details

Alvaro Köhn-Luque

University of Oslo

NORWAY

View details

Michelle Kaku

Assistant Professor of Neurology

Icahn School of Medicine at Mount Sinai

UNITED STATES

View details

Charles Marshall

Clinical Senior Lecturer

Queen Mary University of London

UNITED KINGDOM

View details

Rajiv Mohanraj

Honorary Senior Lecturer

University of Manchester

UNITED KINGDOM

View details

Henry Kaminski

George Washington University

UNITED STATES

View details

Kevin Tan

National Neuroscience Institute

SINGAPORE

View details

Danielle Leighton

Clinical Lecturer in Neurology

University of Glasgow

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ashwin Pinto

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

Association of British Neurologists (ABN) autoimmune myasthenia gravis management guidelines (2025 update)

Personal health records: a practical guide for neurologists

Immune checkpoint inhibitor-associated bilateral optic neuritis

Comparison of IVIg and TPE efficacy in the treatment of neurological disorders: a systematic literature review.

Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome.

Evaluation and improvement of the National Early Warning Score (NEWS2) for COVID-19: a multi-hospital study.

Measuring coping in people with amyotrophic lateral sclerosis using the Coping Index-ALS: A patient derived, Rasch compliant scale

Clinical trials in amyotrophic lateral sclerosis: a systematic review and perspective

Refractory CIDP with chronic lymphocytic leukaemia responding to chemoimmunotherapy

The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial

The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial

Desminopathy presenting as late onset bilateral facial weakness, with diagnosis supported by lower limb MRI

COVID-19-associated risks and effects in myasthenia gravis (CARE-MG).

Collaborators (10)

Catrin Plumpton

Rhys Roberts

Luke Slater

Alvaro Köhn-Luque

Michelle Kaku

Charles Marshall

Rajiv Mohanraj

Henry Kaminski

Kevin Tan

Danielle Leighton

Make your next move.